Business Description
Becton Dickinson & Co
NAICS : 339112
SIC : 3841
ISIN : US0758871091
Share Class Description:
XSWX:BDX: Ordinary SharesTotal Employee Number:
72,000Compare
Compare
Traded in other countries / regions
BDX.USABDX.Mexico0R19.UKBOX.Germany1BDX.ItalyBDX.AustriaB1DX34.BrazilBDX.Switzerland IPO Date
2014-10-27Description
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.72 | |||||
Debt-to-EBITDA | 3.66 | |||||
Interest Coverage | 5.08 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 1.97 | |||||
Beneish M-Score | -2.92 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.9 | |||||
3-Year EBITDA Growth Rate | 3.8 | |||||
3-Year EPS without NRI Growth Rate | 8.3 | |||||
3-Year FCF Growth Rate | 17 | |||||
3-Year Book Growth Rate | -0.1 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 63.46 | |||||
9-Day RSI | 65.27 | |||||
14-Day RSI | 63.39 | |||||
3-1 Month Momentum % | -7.58 | |||||
6-1 Month Momentum % | -34.25 | |||||
12-1 Month Momentum % | -34.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.94 | |||||
Quick Ratio | 0.55 | |||||
Cash Ratio | 0.1 | |||||
Days Inventory | 122.06 | |||||
Days Sales Outstanding | 46.74 | |||||
Days Payable | 63.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.34 | |||||
Dividend Payout Ratio | 0.08 | |||||
3-Year Dividend Growth Rate | 6.1 | |||||
Forward Dividend Yield % | 2.67 | |||||
5-Year Yield-on-Cost % | 1.74 | |||||
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | 9.42 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 46.79 | |||||
Operating Margin % | 14.48 | |||||
Net Margin % | 5.33 | |||||
EBITDA Margin % | 22.09 | |||||
FCF Margin % | 14.34 | |||||
OCF Margin % | 17.96 | |||||
ROE % | 4.53 | |||||
ROA % | 2.1 | |||||
ROIC % | 5.6 | |||||
3-Year ROIIC % | 41.41 | |||||
ROC (Joel Greenblatt) % | 26.38 | |||||
ROCE % | 4.92 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 8 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 38.31 | |||||
Forward PE Ratio | 11.7 | |||||
PE Ratio without NRI | 11.26 | |||||
Shiller PE Ratio | 29.52 | |||||
Price-to-Owner-Earnings | 17.11 | |||||
PEG Ratio | 1.46 | |||||
PS Ratio | 2.02 | |||||
PB Ratio | 1.73 | |||||
Price-to-Free-Cash-Flow | 14.17 | |||||
Price-to-Operating-Cash-Flow | 11.3 | |||||
EV-to-EBIT | 25.8 | |||||
EV-to-Forward-EBIT | 25.9 | |||||
EV-to-EBITDA | 12.32 | |||||
EV-to-Forward-EBITDA | 13.41 | |||||
EV-to-Revenue | 2.72 | |||||
EV-to-Forward-Revenue | 2.92 | |||||
EV-to-FCF | 19.03 | |||||
Price-to-GF-Value | 0.79 | |||||
Price-to-Projected-FCF | 0.94 | |||||
Price-to-DCF (Earnings Based) | 0.95 | |||||
Price-to-DCF (FCF Based) | 1.24 | |||||
Price-to-Median-PS-Value | 0.69 | |||||
Earnings Yield (Greenblatt) % | 3.88 | |||||
FCF Yield % | 7.33 | |||||
Forward Rate of Return (Yacktman) % | 8.84 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Becton Dickinson & Co Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 17,066.395 | ||
| EPS (TTM) (CHF) | 3.189 | ||
| Beta | 0.284 | ||
| 3-Year Sharpe Ratio | -0.43 | ||
| 3-Year Sortino Ratio | -0.5 | ||
| Volatility % | 46.41 | ||
| 14-Day RSI | 63.39 | ||
| 14-Day ATR (CHF) | 1.130598 | ||
| 20-Day SMA (CHF) | 118.993 | ||
| 12-1 Month Momentum % | -34.25 | ||
| 52-Week Range (CHF) | 112.319377 - 175.108305 | ||
| Shares Outstanding (Mil) | 275.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Becton Dickinson & Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Becton Dickinson & Co Stock Events
| Event | Date | Price (CHF) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2026-11-25 | In 146 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-11-06 08:00 | In 128 days | ||
| Fourth quarter earnings results for 2026 | 2026-11-06 | In 127 days | ||
| Third quarter earnings conference call for 2026 | 2026-08-07 08:00 | In 37 days | ||
| Third quarter earnings results for 2026 | 2026-08-07 | In 36 days | ||
| USD 1.050000 Cash Dividend | 2026-06-09 | 120.33 (+0.00%) | ||
| Bank of America Securities Health Care Conference | 2026-05-12 11:40 | 113.57 (+0.00%) | ||
| Second quarter earnings conference call for 2026 | 2026-05-07 08:00 | 113.99 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-05-07 | 113.99 (+0.00%) | ||
| Barclays 28th Annual Global Healthcare Conference | 2026-03-10 08:30 | 128.78 (+0.00%) |
Show
Entries
Becton Dickinson & Co Frequently Asked Questions
What is Becton Dickinson & Co(XSWX:BDX)'s stock price today?
The current price of XSWX:BDX is CHF122.81. The 52 week high of XSWX:BDX is CHF175.11 and 52 week low is CHF112.32.
When is next earnings date of Becton Dickinson & Co(XSWX:BDX)?
The next earnings date of Becton Dickinson & Co(XSWX:BDX) is 2026-08-07 Est..
Does Becton Dickinson & Co(XSWX:BDX) pay dividends? If so, how much?
The Dividend Yield %  of Becton Dickinson & Co(XSWX:BDX) is 1.34% (As of Today), Highest Dividend Payout Ratio of Becton Dickinson & Co(XSWX:BDX) was 0.31. The lowest was 0.08. And the median was 0.29. The  Forward Dividend Yield % of Becton Dickinson & Co(XSWX:BDX) is 2.67%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Articles on Becton Dickinson & Co
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers